In a filing, Conmed Corp revealed its Former Officer Hartman Curt R acquired Company’s shares for reported $0.19 million on Feb 14 ’25. In the deal valued at $64.89 per share,2,905 shares were bought.
Then, Glaze Richard sold 257 shares, generating $16,796 in total proceeds. Upon selling the shares at $65.35, the Chief Information Officer now owns 0 shares.
Before that, Hartman Curt R bought 4,986 shares. Conmed Corp shares valued at $313,869 were divested by the Former Officer at a price of $62.95 per share.
JP Morgan downgraded its Conmed Corp [CNMD] rating to a Neutral from a an Overweight in a research note published on February 06, 2025; the price target was decreased to $70 from $85. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early February has reiterated a ‘”a Buy”‘ rating for it. CL King began covering CNMD with “Buy” recommendation on May 22, 2023. KeyBanc Capital Markets revised its rating on March 27, 2023. It rated CNMD as “an Overweight” which previously was an “a Sector weight”.
Price Performance Review of CNMD
On Tuesday, Conmed Corp [NYSE:CNMD] saw its stock jump 1.24% to $62.74. Over the last five days, the stock has lost -0.11%. Conmed Corp shares have fallen nearly -8.33% since the year began. Nevertheless, the stocks have fallen -22.89% over the past one year. While a 52-week high of $86.96 was reached on 02/05/25, a 52-week low of $59.50 was recorded on 02/21/25. SMA at 50 days reached $68.39, while 200 days put it at $70.13.
Levels Of Support And Resistance For CNMD Stock
The 24-hour chart illustrates a support level at 61.45, which if violated will result in even more drops to 60.15. On the upside, there is a resistance level at 63.75. A further resistance level may holdings at 64.75. The Relative Strength Index (RSI) on the 14-day chart is 39.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.57, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.68%. Stochastics %K at 16.10% indicates the stock is a buying.
The most recent change occurred on March 21, 2023 when Wells Fargo began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $96 price target.
